RNAi modulation of Aha and therapeutic uses thereof

Details for Australian Patent Application No. 2007253803 (hide)

Owner The Scripps Research Institute Alnylam Pharmaceuticals, Inc.

Inventors Bramlage, Birgit; Balch, William; Vornlocher, Hans-Peter; Tan, Pamela; Constien, Rainer

Agent FB Rice

Pub. Number AU-B-2007253803

PCT Pub. Number WO2007/137156

Priority 60/801,840 19.05.06 US

Filing date 18 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 24 May 2012

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/137156 Priority application(s): WO2007/137156

24 May 2012 Application Accepted

  Published as AU-B-2007253803

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007253808-Removable tube heat exchanger with retaining assembly

2007253800-Systems and methods for producing oil and/or gas